Event Overview

Achieving excellence with R&D data will enable the life sciences industry to increase the speed and quality of innovation and is thus a major source of competitive advantage. Whether researchers and informaticians deal with “big data,” “deep data” or just put their data to smarter use, it is clear that the future of R&D is dependent on both smart technologies and clever researchers. The rapid progress of innovation in software and powerful hardware now allows human researchers to interpret masses of raw data in unique ways and is redefining the R&D business model. The benefits range from discovery and “omics” research, through to clinical trials and to real patients in the real-world. However, it is major technical, financial, and operational challenge is to turn “messy” data into structured data, that can be used for advanced analytics that can spot opportunities and achieve true insights. Some of the most promising areas of technological innovation making rapid progress include, for example, artificial intelligence, machine learning, cloud computing and the blockchain (distributed ledgers). There is also huge potential for efficient collaborations between the life science industry, technology companies, academic researchers, health systems, physicians, and health insurers to remove data silos. A deeper convergence between key stakeholders and advanced technologies will facilitate the discovery and development of powerful therapies, devices and advanced diagnostics to benefit patients.

The “R&D Data Intel Leaders Forum” is the must attend event for those senior decision-makers, researchers, data scientists and technologists, looking to make the shift towards an integrated R&D and data strategy and for those looking to improve their implementation of data-driven approaches to enhance R&D specific decision-making and intelligence.

Speakers List

Pharma Industry

Chief Scientific Officer
ERYTECH Pharma, France

VP Early Biometrics and Statistical Innovation, Biopharma R&D
AstraZeneca

Head of Computational Life Science IT
Bayer

Director,Strategy- World Wide Research and Development
Pfizer, USA

Senior Director Computational Biology, Discovery Sciences
Janssen Research & Development

Senior Director, Real World Evidence – External Partnerships Global Commercial Strategy Organisation
Janssen

Senior IT Project Manager Specialized in Health IT
Roche, Switzerland

Health Informatics Director,
AstraZeneca, UK

Head of R&D G3O
Janssen, Belgium

Director, Head of Oncology Bioinformatics
Merck

Head External Innovation Technologies, Global External Innovation & Alliances
Bayer

Director, Head of UK Open Innovation Neurology Business Group
Eisai Limited, UK

Senior Strategic R&D Operations Analyst
Merck

Head of Data Science Advanced Analytics Dept.
Bayer

Senior Investigator II, Modeling & Simulation, Data Science
Novartis

Biotechs

President & CEO
QR Pharma

CSO
Tecrea, UK

CSO/COO
Oncodesign, France

MedTech & Diagnostics

Senior Vice President Information Technology
Hartmann Group, Germany

Global Head of Technology & Innovation Management
Siemens Healthcare

Director External Innovation, Oncology Discovery
Roche Diagnostics, Switzerland

External Stakeholders

Chief Innovation Officer
Catalan Agency for Health Quality and Assessment – AquAS

Thematic Coordinator Molecular Diagnostics Center for Health & Bioresources
Austrian Institute of Technology, Austria

Professor of Pharmaceutical Technologies
University of Greenwich, UK

Co-Director Noncoding RNA Core
Institute for RNA medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, USA

Head of Design and Product Development
Arnhold Institute for Global Health, USA

Founder
Institute for Interdisciplinary Innovation in healthcare, Université Libre de Bruxelles, Belgium

(TBC)

Ass. Professor
University of Natural Resources and Life Sciences

Technology Companies

CEO and Co-Founder
Phenomic AI

Head of Strategy
Horizon Discovery, UK

Data Analytics Specialist
Google Cloud, Switzerland

Event Structure

Photo Gallery

Event Overview

Strategic Developments in R&D Innovation

Day 1 - 27th January, 2020

Stream Overview

Data is redefining the R&D model and enabling better decision-making and innovation. Senior-level thought leaders from both the R&D and technology perspectives will be presenting the best technologies and approaches of today which are already creating a proven impact in R&D and which will be crucial for the research demands of tomorrow. These speakers will also discuss which technological, financial, regulatory, and operational challenges need to be overcome to ensure that key insights are achieved, and that patients’ benefits are dramatically enhanced through R&D intelligence.

Speakers

Chief Scientific Officer
ERYTECH Pharma, France

VP Early Biometrics and Statistical Innovation, Biopharma R&D
AstraZeneca

Head of Computational Life Science IT
Bayer

Director,Strategy- World Wide Research and Development
Pfizer, USA

Senior IT Project Manager Specialized in Health IT
Roche, Switzerland

President & CEO
QR Pharma

Senior Vice President Information Technology
Hartmann Group, Germany

Global Head of Technology & Innovation Management
Siemens Healthcare

Chief Innovation Officer
Catalan Agency for Health Quality and Assessment – AquAS

Data Analytics Specialist
Google Cloud, Switzerland

18.30 NETWORKNG DINNER

External Innovation for Enhancing R&D

Day 2 - Stream 1 - 28th January, 2020

Stream Overview

This stream is focused on how pharmaceutical innovation can be enhanced through intelligent and novel external collaborations. Almost all pharma and medtech companies now believe that they key to innovation is not purely through performing R&D in-house, but through partnerships with biotechs, academic or government institutes to tap unique sources of knowledge, capabilities, resources and technologies. However, there are a myriad of different models of external collaborations, which may include classical one-on-one partnerships, but increasingly unique “open-innovation” or partnering with larger-scale R&D consortia to pool risks and resources and know-how. Attendees will hear real life case studies and success stories and learn about what collaborative models, practices and approaches have actually resulted in R&D innovations which promise great commercial success.

Speakers

Senior Director, Real World Evidence – External Partnerships Global Commercial Strategy Organisation
Janssen

Head of R&D G3O
Janssen, Belgium

Head External Innovation Technologies, Global External Innovation & Alliances
Bayer

Director, Head of UK Open Innovation Neurology Business Group
Eisai Limited, UK

CSO
Tecrea, UK

CSO/COO
Oncodesign, France

Director External Innovation, Oncology Discovery
Roche Diagnostics, Switzerland

Founder
Institute for Interdisciplinary Innovation in healthcare, Université Libre de Bruxelles, Belgium

Discovery & Omics Data Excellence

Day 2 - Stream 2 - 28th January, 2020

Stream Overview

This stream will focus on how to plan and implement data-driven approaches in the drug discovery process to unlock innovation. Huge volumes of raw data can be merged with other data sets, structured, and analysed from a myriad of perspectives, not just to achieve answers to complex research questions, but also to develop new hypotheses. Attendees will understand how a dedicated R&D data strategy for precision medicines and large “Omics” data volumes can achieve deep insights that enhance R&D decision making and innovation.

Speakers

Health Informatics Director,
AstraZeneca, UK

Thematic Coordinator Molecular Diagnostics Center for Health & Bioresources
Austrian Institute of Technology, Austria

Co-Director Noncoding RNA Core
Institute for RNA medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, USA

Head of Design and Product Development
Arnhold Institute for Global Health, USA

CEO and Co-Founder
Phenomic AI

Head of Strategy
Horizon Discovery, UK

Data Intel: Advanced Analytics & AI

Day 3 - Stream A - 29th January, 2020

Stream Overview

The critical challenges of R&D have pushed pharma companies to investigate new ways of improving innovation, including manipulating more sophisticated analytics and cutting-edge tools like AI. This stream will focus on practical ways to achieve fresh insights and drive portfolio decision making using with these tools, resulting in a more efficient and cost saving R&D process.
In this stream, decision-makers will deepen their ability to effectively implement both AI & analytics in R&D by learning from experts and thought leaders in the field. Senior executives will have the opportunity to tap into exclusive insights and know-how, in terms of the most groundbreaking technological solutions to the R&D productivity problem. Every participant can expect to leave understanding how to reduce risk and add certainty in their R&D portfolio using predictive analytics and AI.

Speakers

Senior Director Computational Biology, Discovery Sciences
Janssen Research & Development

Director, Head of Oncology Bioinformatics
Merck

Senior Strategic R&D Operations Analyst
Merck

Head of Data Science Advanced Analytics Dept.
Bayer

Senior Investigator II, Modeling & Simulation, Data Science
Novartis

(TBC)

Ass. Professor
University of Natural Resources and Life Sciences

Training Workshop: Persuasion & Negotiation Skills for Scientific & Technical Professionals

Day 3 - Stream B - 29th January, 2020

Essential tactics to engage and understand stakeholders, influence them and communicate the value of your solutions or opportunities.

This unique training course is specifically tailored towards life science professionals who need to learn powerful soft skills. Those who attend will engage more external stakeholders (KOLs, Clinicians, MoH) or customers, stand out from the competition, overcome objections and better "sell" the true value of their solutions, proposals or opportunities

What's the unmet need?

We at NextLevel Life Sciences, have a unique perspective on how life science professionals can dramatically and immediately improve their influence & persuasiveness. At our industry events, we constantly observe our clients’ successful interactions, but also missed opportunities. For example, many executives in life sciences companies are true subject-matter or technical experts. Often, however, they haven't received any structured training on negotiation, influence and persuasion, so are not maximising their chances of ensuring the most from each customer interaction.

We have recognised a strong need for a structured and interactive course which will definitely help life sciences professionals to engage stakeholders, appreciate their needs, positively influence them, demonstrate true value and forge lasting business relationships.

Who are your trainers?

Geoff Cable                               
CEO & co-Founder                         
NextLevel Life Sciences
 

Luke Rogers
CEO & co-Founder
NextLevel Life Sciences


"We believe that sales isn't a job, it's a life skill"

Geoff and Luke are experts in soft skills, negotiation, business development, management & entrepreneurship. They have a strong track record of growing their successful company organically, through sales and marketing. Both are Australians and also CEOs and co-founders of NextLevel Life Sciences, a leading event organiser and business intelligence provider for the Biopharma and Medtech industries. Over the last 12 years, Luke and Geoff have developed, promoted and delivered hundreds of industry events, focused on cutting-edge or critical themes. These have involved thousands of senior-level attendees from all the major pharma, medtech, biotech and diagnostics companies, as well as a broad range of service providers and key industry stakeholders. NextLevel Life Sciences has a strong value proposition, an effective process, but especially a customer-centric sales philosophy.

Senior R&D executives: Scientific Officers, Chief Information Officers, Chief Technology Officers, Knowledge & Data Management (Discovery, Clinical & Real-World Data), R&D Analytics, Informatics, R&D Innovation, External Alliances & Innovation, R&D Strategy.

Drug Discovery: Drug Discovery, R&D, Lead Identification & Target Validation, Screening, Translational R&D, Genomics & Proteomics, Biomarker R&D, Senior Scientist, Biostatistics, Biometric, Precision Medicine, Personalised Medicine, Computational Biology

External Innovation: Business Development, Strategic Collaborations, Alliances, External Innovation, Consortia, Partnerships

R&D Analytics & AI: Data Analyst, Data Scientist, Bioinformatician, Bioinformatics, CIO, AI, Machine Learning

Media Partners

This event is accredited for CPD (Continuing Professional Development) status

RECEIVE DISCOUNTED FLIGHTS WHEN YOU REGISTER FOR THIS EVENT WITH

Previous Attendees at R&D Data Intelligence Leaders Forum - Basel, Switzerland, 2019

Company
Job Title
2KMM
CEO
2KMM
Data Management and Analysis Assistant
Almirall S.A
Molecular Informatics R&D Specialist
Almirall S.A
R&D IT Business Partner & SVC Delivery
Amgen Switzerland
Medical Director
aparito
Founder & CEO
Bayer
IT Business Partner
Bayer
IT Business Partner Research
Bayer
Director, Medicinal Chemistry
Bayer Business Services GmbH
IT Business Partner Medical Affairs & Pharmacovigilance
Bayer Consumer Care
Digital GxP Compliance Manager
Biogen
Principal Scientist
Boehringer Ingelheim
IT Architect
Catholic University of Korea
Professor
Center for Research and Interdisciplinarity (CRI)
Managing Director
ChemAxon
Account Manager
ChemAxon
Senior Application Scientist
CSL Behring
Head Breakthrough Technologies
CureVac
Co-founder and Chairman of the Supervisory Board
Dacadoo
President and CEO
Databricks
Life Sciences Lead
Deloitte ConvergeHEALTH
Senior Manager
Deloitte UK Centre for Health Solutions
Research Manager
DNAnexus
CEO
docdok.health
Co-Founder & CEO
e-therapeutics
Head of Discovery Informatics
European Connected Health Alliance
Chair
Evonetix
CEO
Exscientia
Head of Chemoinformatics
F. Hoffmann-La Roche
Biology Workflow Team Leader
F. Hoffmann-La Roche
Head of Small Molecule Discovery Workflows
F. Hoffmann-La Roche
Research Informatics Scientist
F. Hoffmann-La Roche
Principal Scientist
F. Hoffmann-La Roche
Senior Scientist
F. Hoffmann-La Roche
Personalised Healthcare CoE
F. Hoffmann-La Roche AG
Head of Business Intelligence Finance, Operations, Site Services, Q&R Analytics
F. Hoffmann-La Roche Ltd
Group Manager EU/International Clinical Trial Regulatory Management
FeetMe
Co-founder and CEO
GE Healthcare
Global Digital Services Transformation Leader
Genedata
Business Development Manager
Getinge
Systems Architect
Google Cloud
Sr. Program Manager, Healthcare & Life Sciences
GSK
Head Computational Biology and Stats
Helbling
Head of Development
Helbling
Development Engineer
Hoffmann La Roche
Strategic Analytics Manager
icometrix
CEO
Idorsia Pharmaceuticals
Head of Translational Science
Iktos
Founder and CEO
Iktos
CSO
Image Analysis Group
CEO
Insilico Medicine
CTO
Intellegens
CTO
Janssen Pharmaceuticals
Senior Associate Scientist
Johnson & Johnson
Associate Director Integrated Clinical & Operational Analytics
Linguamatics
Senior Account Manager, Europe
Lupus Friends and Family Foundation
Founder & President
Medisafe
VP Pharma (EMEA)
Medtronic
EMEA privacy consultant
Merck Sharp and Dohme
Senior Vice President and Head Global Clinical Development, Chief Medical Officer
Nebion
CEO
Nebula Genomics
Co-founder
NHS Foundation Trust
Director of Innovation and Development
Novartis
Global Head Technology, Architecture, Digital Drug Development
Novartis
Associate Director, Information Systems
Novartis
Global Head of Portfolio Management, Medical, Digital and RWE Solutions
Novartis
Asc. Director Knowledge Management
Novartis
Data Science & A.I. Technical Advisor
Novartis
Head Data Governance
Novo Nordisk A/S
Senior Director
Novo Nordisk A/S
Head of Non-clinical Data Management
Novozymes
R&D Director, BioEnergy
Novozymes
Group Leader, Automation and Digitalization, R&D
Numerate
CSO
Philips
Principal Scientist - Medical Biomarker Research Oncology
Philips Research
Vice President, Member Program Board Healthcare Healthcare Strategic Partnerships
Pierre Fabre
BioInformatics Platform Director
Pool Global Partners
Entrepreneur in Residence
Pool Global Partners, USA
Founder and Managing Partner
Quantitative Biology Center Tübingen
Centre Head
Roche
Senior IT Project Manager Specialized in Health IT
Roche
Group Head Clinical Trials, Regulatory Management
Roche
Principal Scientist, Toxicology Project Leader
Roche Innovation Center Basel, Switzerland
Principal Scientist, Scientifc Information Management
Sanofi
Director of scientific relations R&D Europe
Shivom
Founder & CSO
Siemens Healthineers
Head of Digital Technology & Innovation
Technical University Dresden
Professor in Bioinformatics, BIOTEC and Dept. of Computing
TheraPanacea
Chief Executive Officer / Chief Scientist
Thomas Jefferson University and Jefferson Health System
Chief Digital Officer and Senior Vice President for Technology Innovation and Consumer Experience
University of Colorado
Distinguished Professor
University of Southampton
Research Fellow , Clinical Informatics Research Unit
University of Surrey
Professor of Machine Intelligence
University of Zurich
Professor of Bioinformatics, Institute of Molecular Life Sciences (IMLS) and Swiss Institute of Bioinformatics (SIB)
Zebra Medical Vision
Co-Founder and CTO

Related Videos

Presentation

Measuring the return from pharmaceutical innovation 2018

Related topics: Discovery & R&D Innovation, Digital & Technology
Availability: FREE

The biopharma industry continues to face challenges this year, with projected returns on investment in R&D at the lowest levels since our analysis began in 2010. However, there are opportunities to reverse this trend, which will require new ways of working and a complete digital transformation to unlock R&D productivity and deliver the next generation of scientific breakthroughs.

Speaker

Mark Steedman
Research Manager
Deloitte UK Centre for Health Solutions

Presentation

Extreme-Scale Cloud-Based Infrastructure needed for global genomic data

Related topics: IT & Big Data
Availability: FREE
  • Cloud genomic data sets are approaching a total of 250 Petabytes representing an unprecedented resource for research and clinical applications
  • Extreme-scale cloud-based compute and tools are required to federate and utilize the emerging global resource, conforming to localized compliance requirements
  • A rapid evolution in data resource architecture and applicable tools is required, with an important role to be played by Artificial Intelligence
Speaker

Richard Daly
CEO
DNAnexus, Inc., USA

View Agenda or Register